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OBJECTIVES We sought to evaluate the feasibility of identifying and ablating the substrate of unmappable
ventricular tachycardia (VT).
BACKGROUND Noninducible and nonstable VT cannot be ablated by the conventional approach.
METHODS We studied 24 patients with documented monomorphic VT. Twenty-one patients had
ischemic cardiomyopathy, two had nonischemic cardiomyopathy, and one had tetralogy of
Fallot. Twelve patients had an implantable cardioverter-defibrillator. Conventional activation
mapping was not possible in 18 patients: at least 1 of the clinical VTs or the clinical VT was
not inducible in 12 patients, and VT was not tolerated in 6 patients. This group had
experienced between 1 and 106 VT episodes in the month before the ablation procedure.
Endocardial electroanatomic activation maps (Carto System) during sinus rhythm (SR) and
right ventricular apex (RVA) pacing were obtained to define areas for which an electrogram
displayed isolated, delayed components (E-IDC). These electrograms were characterized by
double or multiple components separated by 50 ms.
RESULTS One area of E-IDC was recorded in 20 patients, and 2 or more were recorded in 4 patients.
In 23 patients, these areas were detected during RVA pacing; in only 14 during SR. An
E-IDC area related to the clinical VT was identified in each patient. Ablation guided by
E-IDC suppressed all but one clinical VT whose inducibility suppression was tested. During
a follow-up period of 9 4 months, three patients had recurrences of the ablated VT and two
of a different VT.
CONCLUSIONS Electrograms with IDCs related to clinical VT can be identified in the majority of patients
during RVA pacing. Radiofrequency ablation of E-IDC seems effective in controlling
unmappable VT. (J Am Coll Cardiol 2003;41:81–92) © 2003 by the American College of
Cardiology Foundation
Slow conduction areas are part of the substrate of the
reentrant circuits in most sustained monomorphic ventric-
ular tachycardias (SMVTs) occurring in patients with struc-
tural heart disease (1). This part of the reentrant circuit has
been classically characterized by the recording of presystolic
isolated electrograms during tachycardia (2–8). The identi-
fication of this component of the circuit requires careful and
time-consuming endocardial mapping, a procedure that is
not feasible in noninducible or nontolerated ventricular
tachycardia (VT). Slow conduction takes place on the
border of the scar tissue; therefore, abnormal and low
amplitude electrograms have been recorded during sinus
rhythm (SR) at these sites. As low-amplitude electrograms
are recorded all along the scarred endocardial surface, they
have low specificity for VT substrate identification (9). We
hypothesized that the recording of electrograms displaying
an isolated, delayed component (E-IDC), characterized by
double or multiple components separated by very-low-
amplitude signals or isoelectric intervals, could better iden-
tify SMVT related slow conduction areas than low-
amplitude electrograms. Nevertheless, fractionated and late
electrograms are rarely recorded during SR (10). Overlap-
ping of electrograms or a particular orientation of a line of
block with respect to the activation front may preclude the
identification of multiple components during SR; this lim-
itation can be overcome by changing the activation front
(11–13). We presumed that a different propagation front,
such as during right ventricular apex (RVA) pacing, could
identify E-IDCs otherwise not detected.
The purpose of this study was to assess: 1) the incidence,
location, and extension of E-IDC in patients with clinical
SMVT and structural heart disease; 2) the feasibility of
relating E-IDC to documented clinical SMVT; and 3) the
efficacy of E-IDC ablation as treatment of noninducible
and/or nontolerated VT.
METHODS
Population. In this protocol, approved by the Research
and Ethical Committee of our institution, we included 24 of
38 consecutive patients with structural heart disease and
SMVT documented by the 12-lead electrocardiogram
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(ECG) who were referred for radiofrequency ablation
(RFA).
Conventional treatment was considered not suitable in 18
patients (Patient nos. 1 to 18) (Table 1). Twelve patients
were considered as noninducible because no clinical VT (n
 9) or the most recently recorded VT and that responsible
for the multiple episodes was not induced (n  3: patient
nos. 4, 9, and 17). In six additional patients, the induced
clinical VT was not tolerated.
The remaining six patients (Patient nos. 19 to 24) (Table
1) with a clinically inducible and well-tolerated VT were
included to: 1) obtain activation maps during SR/RVA
pacing and during VT; and 2) compare the successful
ablation site, guided by activation and entrainment mapping
criteria, with the limits of the E-IDC area.
Seventeen patients had multiple VT episodes despite the
use of amiodarone or sotalol. In seven patients, despite few
VT episodes, RFA was the first option of treatment,
according to our policy of offering RFA when: 1) the VT
remained unnoticed due to the slow rate until heart failure
appeared; 2) patients refused to follow long-term anti-
arrhythmic treatment; and 3) it was adjuvant therapy to
implantable cardioverter-defibrillator (ICD) placement
when the VT was rapidly syncopal and we presumed the
ICD could not terminate the VT before the appearance of
syncope.
Study protocol (Fig. 1). ELECTROPHYSIOLOGIC STUDY.
After written, informed consent was obtained, an electro-
physiologic study was performed in the post-absorptive
state. At least two or three quadripolar catheters were placed
at the right atrium, His bundle area, RVA, or right
ventricular outflow tract. The distal pair of electrodes was
used for pacing, and the proximal pair for local electrogram
recording. Intracardiac recordings were filtered at 30 to 500
Hz and displayed simultaneously with four to six ECG leads
at a paper speed of 100 to 200 mm/s on a 12-channel
recorder (Midas, Hellige Biomedical, Freiburg, Germany).
Stimulation was performed with a programmable stimulator
(UHS-20 Biotronik, Berlin, Germany) set to deliver rect-
angular pulses of 2-ms duration at twice the diastolic
threshold. Programmed stimulation was performed to in-
duce VT through triple extrastimuli at two right ventricular
sites.
Mapping of the left and right ventricles: location of
E-IDC. Detailed endocardial mapping was performed
during SR and during pacing at RVA at 600 ms. In 22
patients, mapping and ablation were performed using the
Carto (Biosense-Webster, Waterloo, Belgium) magnetic
mapping system with the Navistar catheter. The Navistar
bipole consists of a 4-mm-tip electrode and 2-mm-ring
electrode separated by 1 mm of spacing. Bipolar electro-
grams were filtered at 30 to 400 Hz and displayed at 100
mm/s; peak-to-peak amplitude was measured automatically.
The magnetic mapping system includes a magnetic sensor in
the catheter tip that can be localized in a three-dimensional
space using the ultra-low-frequency magnetic field generators
placed under the fluoroscopic table. This system permits
three-dimensional reconstruction of the endocardium, which
can be shown on a computer display (14,15).
To define the limits of the area demonstrating E-IDC,
once an E-IDC was identified, multiple sites were explored
around it to obtain a distance of 1 cm between the
mapped sites. The E-IDCs were labeled for rapid location
on the maps. Activation maps were reconstructed taking the
peak of the largest deflection of every single electrogram as
the local activation time.
The Carto system can display the amplitude of bipolar
electrograms as voltage maps. When multiple-component
electrograms were recorded, the voltage of the largest
component was automatically selected. The color display on
the voltage map was set to a color range of 0.5 to 1.5 mV to
distinguish the limits of the scar. We differentiated between:
1) complete scar, displayed in gray, characterized by elec-
trograms with a voltage amplitude 0.1 mV; and 2) dense
scar, displayed in red, with an electrographic amplitude
0.1 and0.5 mV. We measured the distance between the
E-IDC area limit and the closest border of the dense scar to
determine whether RFA lesions could affect normal myo-
cardium or whether a hypothetical ablation line along the
border of the scar could have eliminated the E-IDC.
Clinical VT and E-IDC. After the maps were completely
depicted, in order to relate a particular E-IDC area to
clinical VT, pace mapping was performed starting at the
electrogram showing the latest isolated, delayed component
(E-LIDC). When the QRS morphology in clinical VT was
not reproduced from the E-LIDC, VT morphology was
analyzed and a site from the limits of the E-IDC area was
selected for pacing. After an identical or similarly paced
QRS interval, defined by the same R/S ratio in all leads, was
obtained, we proceeded to induce VT.
We assumed a relationship between E-IDC and clinical
VT when the following criteria were met: 1) noninducible
VT: pace mapping reproducing the QRS morphology in
clinical VT and the stimulus to QRS interval (S-QRS)50
ms; 2) inducible but poorly tolerated VT: presence of a
pre-systolic or mid-diastolic electrogram and a difference
Abbreviations and Acronyms
E-IDC  electrogram displaying isolated, delayed
component
E-LIDC  electrogram displaying latest isolated, delayed
component
E-QRS  electrogram’s QRS interval
ICD  implantable cardioverter-defibrillator
RFA  radiofrequency ablation
RVA  right ventricular apex
SMVT  sustained monomorphic ventricular
tachycardia
S-QRS  stimulus to QRS interval
SR  sinus rhythm
VT  ventricular tachycardia
82 Arenal et al. JACC Vol. 41, No. 1, 2003
Ablation of Unmappable VTs January 1, 2003:81–92
30 ms between the electrogram’s QRS interval (E-QRS)
in VT and S-QRS when the preceding pace map was
similar; and 3) well-tolerated VT: presence of a pre-systolic
or mid-diastolic electrogram, concealed entrainment, and a
first post-pacing interval–VT cycle length difference 30 ms.
Radiofrequency ablation. Radiofrequency energy was de-
livered as a continuous, unmodulated sine wave of 500 kHz
between the distal electrode of the ablation catheter and a
large skin electrode on the posterior chest.
The conventional RFA approach was followed in the six
patients (Patient nos. 19 to 24) (Table 1) in whom clinical
VT was induced and tolerated; radiofrequency energy was
only delivered at sites identified by conventional entrain-
ment mapping criteria.
In Patients 1 to 18, in whom clinical VT was unmap-
pable, an E-IDC area was considered as a RFA target, and
all E-IDC sites were ablated provided that: 1) pace mapping
from any E-IDC site, usually the E-LIDC, in the area
reproduced the target clinical VT with S-QRS 50 ms; or 2)
any E-IDC became mid-diastolic during VT induction. The
induction of a different VT, even if it was tolerated, did not
modify the RFA approach, provided that no mid-diastolic
electrogram during VT was recorded outside the E-IDC area.
The target temperature was 60°C. All lesions were delivered
for at least 1 min, unless a rise in impedance was noted.
The end points of the procedure were: 1) disappearance
of all IDCs of a clinical VT-related area in those patients
with unmappable VT; and 2) inducibility suppression of
clinical VT. Heparin was infused throughout the procedure.
To those patients in whom VT was not inducible or
inducibility suppression was not tested, ICD implantation
was advocated.
Definitions. E-IDC. Electrograms recorded in the scar tis-
sue showing double or multiple components separated50 ms
Table 1. Patient Characteristics
Patient
No.
Age (yrs)/
Gender
Heart
Disease
LVEF
(%) ICD
CVT
(ms) Episodes
IVT
(ms) LCT
1 67/M IC 25  RRS (370) 36/month — NI
2 69/F DCM 20  RRS (400) 10/week — NI
RLS (450) —
3 74/M IC 40  RLS (320) 1 RLS (310) NT
4 65/M IC 30  RRI (340) Multiple/week — NI
RRS (350) RRS (370)
5 67/M IC 25  RRS (300) 1 RRS (300) NT
6 56/M IC 30  RLS (400) 94/month — NI
7 58/M IC 34  LRI (300) 1 LRI (300) NT
8 68/M IC 55  RLS (280) 1 RLS (280) NT
9 72/M IC 35  RRS (400) Multiple/week — NI
RLS (380) —
RLI (400) RLI (480)
10 72/M IC 25  RRS (380) 11/month — NI
11 74/M IC 25  RLS (320) 1 RLS (310) NT
LLS (300)
12 59/M DCM 25  RRS (360) 16/month RRS (380) NS
RLS (280)
13 28/M TF 55  RRI (440) 3/month LLS (430) NI
14 71/M IC 20  LRI (420) 25/month — NI
15 73/M IC 40  RRS (380) 3/month — NI
16 73/M IC 20  LRI (360) 1/month LLS (270) NI
17 67M IC 20  RRS (420) 55/month NI
RLS (380) RRS (400)
RRS (400) RRI (400)
18 64/M IC 30  RRS (400) 1/month — NI
19 72/F IC 27  RRS (360) 10/week RRS (380)
LLS (400)
20 51/M IC 35  RRI (350) 6/week RRI (350)
21 70/M IC 25  LLI (500) 5/week LLI (540)
22 71/M IC 45  RLS (480) 106/month RLS (480)
RLI (400)
23 72/M IC 35  LLS (400) 4/week LLS (380)
24 74/M IC 30  RRS (420) 29/month RRS (440)
Mean  SD 66  9 30  9
CVT  clinical ventricular tachycardia; DCM  dilated cardiomyopathy; F  female; IC  ischemic cardiomyopathy; ICD  implantable cardioverter-defibrillator; IVT 
induced ventricular tachycardia; LCT  limitation of conventional treatment; LVEF  left ventricular ejection fraction; LLI  left bundle branch block left inferior axis; LLS
 left bundle branch block left superior axis; LRI  left bundle branch block right inferior axis; M  male; NI  noninducible; NS  nonstable; NT  nontolerated; RLI 
right bundle branch block left inferior axis; RLS  right bundle branch block left superior axis; RRI  right bundle branch block right inferior axis; RRS  right bundle branch
block right superior axis; TF  tetralogy of Fallot.
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by very low amplitude signals or an isoelectric interval. During
RVA pacing, the activation time of the latest component from
the stimulus artifact had to be 150 ms.
E-QRS. During VT, this was the interval from the mid-
diastolic electrogram to the following QRS onset.
E-LIDC. This was considered as the E-IDC showing the
longest activation time to the last component either from
the QRS onset during SR or the stimulus artifact during RV
pacing.
POST-PACING INTERVAL–VT CYCLE LENGTH DIFFERENCE.
This was the difference between the post-pacing interval
and the tachycardia cycle length.
S-QRS. This was the interval from the stimulus to the onset
of the following QRS complex during pacing from the
E-LIDC.
S-QRS–E-QRS DIFFERENCE. This was the difference between
the S-QRS interval during pacing from the E-LIDC on SR
and the E-QRS interval during VT.
E-IDC AREA. This was the area circumscribing the sites
where E-IDC were recorded; we considered the presence of
a distinct area when the distance between the closest E-IDCs
was 20 mm due to the presence of normal or scar tissue.
Statistical analysis. Data are expressed as the mean value
 SD. Comparisons were performed using the Student t
test and Fisher exact test. A probability value of 0.05 was
considered significant.
RESULTS
Table 1 shows the characteristics of clinical and induced
VT.
Endocardial maps: E-IDC location (Table 2). Ventric-
ular maps were constructed using 111 27 points (range 70
to 146). Twenty-nine E-IDC areas were detected: 12 were
defined in 12 of 22 patients during SR (2 patients under-
went permanent pacing); 11 of these areas were also
detected during RVA pacing. The remaining 17 E-IDC
areas were only detected during RVA pacing. Therefore, the
E-IDC was detected in 12 of 22 patients during SR and in
23 of 24 patients during RVA pacing (p  0.01) (Fig. 2).
Four patients (nos. 18, 19, 21, and 24) had two or three
different areas; the remaining patients had only one. An
E-IDC with more than two components was recorded in 26
of 29 E-IDC areas and in 24 of 26 areas in 21 patients with
ischemic heart disease. The following data were obtained
during RVA pacing. Extension of the E-IDC area (3.5 
2.6 cm2 [range 1 to 12]) was smaller than the area with a
Figure 1. Diagram showing the approach to mapping and radiofrequency
(RF) ablation of ventricular tachycardia (VT). E-IDC  electrogram
displaying isolated, delayed component; RVAP  right ventricular apex
pacing; SR  sinus rhythm.
Table 2. Mapping Characteristics
E-IDC Areas
Patient
No.
E-IDC
Loc.
E-IDC
Recording
I-LIDC
(RVAP/SR)
(ms)
E-IDC
With >2
Components
(RVAP/SR)
1 1 RVAP/SR 270/250 /
2 7-1 RVAP 260/— 
3 6-8 SR —/130 
4 5-7 RVAP/SR 240/300 /
5 8 RVAP 200/— 
6 5-6 RVAP/SR 280/200 /
7 2-3 RVAP/SR 250/140 /
8 5-6 RVAP/SR 190/130 /
9 6-8 RVAP 250/— 
10 1-2-11 RVAP 230/— 
11 6 RVAP 210/— 
12 7-8 RVAP 220/— 
13 1 RVAP/SR 180/80 /
14 1-2 RVAP 150/— 
15 6-8 RVAP 180/— 
16 1-11 RVAP 200/— 
17 1-9-11 RVAP/SR 230/140 /
18 1-2 RVAP/SR 245/110 /
11-3* RVAP/SR 260/110 /
19 1-2 RVAP/SR 160/180 /
11-9* RVAP/SR 150/140 /
20 8-10 RVAP 230/— 
21 3 RVAP 240/— 
1* RVAP 220/— 
22 8-10 RVAP/SR 280/190 /
23 6 RVAP 220 
24 7 RVAP/SR 220/140 /
5* RVAP 190/— 
10* RVAP 200/— 
Mean  SD 220  34/143  54
*E-IDC areas that were not related to any clinical ventricular tachycardia.
E-IDC  electrogram with isolated, delayed component; I-LIDC  interval
between the stimulus artifact or QRS onset and the latest isolated delayed component;
Loc.  ventricular segment location of E-IDC (mapping schema in ref. 10); RVAP
 right ventricular apex pacing; SR  sinus rhythm.
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Figure 2. Three examples in which the E-IDCs were recorded only during RVA pacing. Four ECG surface leads are recorded, along with intracardiac electrograms from the His area, RVA, and left ventricle
(LV) during RVA pacing and SR. Notice that in the three examples, during RVA pacing, a small and late component separated by an isoelectric line appears. This component is not evident during SR.
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Figure 3. Voltage map showing the location of the E-IDC area. This map during RVA pacing shows a right and inferior view of the septum and inferior walls of the left ventricle (LV) in a patient with
ischemic heart disease. The color range represents the voltage amplitude. Red denotes dense scar, and gray denotes complete scar. Blue dots show sites where E-IDCs surrounded by complete scar were
recorded. The arrows show the electrogram recorded at the entrance of the corridor (pink dot), at the E-LIDC site, and at the site where multiple components were recorded. Red dots denote the E-IDC
sites where radiofrequency energy was delivered. (A) Clinical VT. (B) Pace map from the E-LIDC reproducing the VT morphology with a long S-QRS interval.
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Figure 4. Induction of VT from the RVA during the recording of E-ILDC. (A) Four ECG surface leads and intracardiac recordings from the His area, RVA, and left ventricle (LV) are recorded during RVA pacing.
The introduction of two extrastimuli provoked the lengthening of the activation time of the E-LIDC and the induction of VT. The E-LIDC preceded the first VT beat and became mid-diastolic. (B) Voltage map
showing all E-IDC sites of the area (blue dots). 87
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Figure 5. (A) Voltage map obtained during RVA pacing. The E-IDCs were recorded in the space located between the inferior and superior scars. Continued on next page.
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Figure 5 Continued. (B) Activation map recorded during VT. The color index reveals the continuity between the earliest and latest activated areas typical of reentry. The E-IDC during RVA pacing and
mid-diastolic electrogram of VT have the same morphology and are recorded at the same site. LV  left ventricle.
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voltage 0.5 mV, including complete and dense scar (22 
11 cm2 [range 11 to 50]; p  0.01) (Fig. 3). The E-IDCs
were recorded close to the border but inside the dense scar.
The minimum distance from the limit of the E-IDC area to
the border of the scar, defined by the distance to the closest
electrogram of 0.5 mV, was 1.6  0.6 cm. The voltage of
the E-LIDC was 0.26  0.11 mV (range 0.11 to 0.5),
which was similar to the voltage of the electrogram recorded
at the sites where VT was successfully ablated (0.27  0.11
mV [range 0.1 to 0.5]; p  0.5 [NS]). The maximum
voltage recorded inside the E-IDC areas was 0.41  0.23
mV (range 0.19 to 1.2).
Relationship between E-IDC and clinical VT. From a
total of 29 E-IDC areas, 24 were related to documented
clinical VTs (Table 2).
In the 18 patients (Patient nos. 1 to 18) with unmappable
VT, 22 of 24 recorded clinical VTs could be related to the
E-IDC areas. Fifteen VTs in 15 patients were reproduced
during pace mapping from the E-LIDC (S-QRS interval
110  45 ms) (Fig. 3). Four additional VTs were repro-
duced from the limits of the E-IDC area. Three more
clinical VTs, despite a different pace map, could be related
to the E-IDC by the fact that during VT induction, the
E-LIDC preceded the first VT beat and then became
mid-diastolic (Fig. 4). Two tachycardias—morphologies of
right bundle branch block left superior axis in Patient no. 2
and right bundle branch block right inferior axis in Patient
4—could not be related to the E-IDC area. In five patients
in whom the pace map and the induced VTs were identical,
the difference between the S-QRS and E-QRS was 8 
8 ms, suggesting that these electrograms were near the
central isthmus of the circuit. In this group, three induced
VTs, different from the target clinical VT, were tolerated
and mapped, as no mid-diastolic electrogram was recorded
outside the E-ICD area; the RFA approach was not
modified. Among the six patients with clinically inducible
and well-tolerated VT, three had successful ablation sites
that were undoubtedly inside the E-IDC area, and in two
other patients, these sites were just within the limits of the
E-ICD area (20 and 16 mm away from the E-LIDC). In
one patient, we could not ablate the VT. Complete activa-
tion maps during VT were obtained in three patients. In one
of these cases, we identified during RVA pacing a slow
conduction area connecting the E-IDC recorded between
two scar areas. During tachycardia, this area functioned as
the central pathway of the circuit (Fig. 5).
Ablation results and duration of procedure. Between 1
and 35 (11  8) RFA lesions were applied per patient. In
patients with unmappable VT, from 3 to 12 (6  2) IDC
sites were ablated using from 3 to 35 (13  8) RFA lesions.
Previously inducible VT became noninducible in all but
patient no. 19. Inducibility suppression was not tested in
Patients 12 and 17 because of hemodynamic instability.
After the ablation procedure, ventricular fibrillation was
induced in Patients 8 and 15, and a fast, nonclinical VT was
induced in Patients 7, 9, 16, 23, and 24. The total procedure
time ranged from 142 to 448 min (mean 232  67). The
total fluoroscopy time ranged from 25 to 105 min (mean 56
 28). There were no complications during the procedure.
After the RFA procedure, three additional patients re-
ceived an ICD (Patients 4, 7, and 8). Despite the fact that
some VTs were not inducible or nonsuppressed, Patients 2,
17, and 19 were not considered as candidates to receive an
ICD, based on their very short life-expectancy. Patients 9
and 16 with noninducible VT refused an ICD implant.
Follow-up (Table 3). During the follow-up period of 9 
4 months, four patients died. Three patients (Patients 2, 17,
and 19) died of congestive heart failure. These patients were
in functional class III/IV before the ablation procedure.
Patient 21 died of a noncardiac cause six months after
ablation, without recurrence of VT. Patient 7 had ventric-
ular fibrillation treated by the defibrillator. Five patients had
VT recurrences. The morphology of the VT recurrence was
different from the previous clinical VT in Patients 14 and
17. Patients 4, 18, and 19 had recurrences of clinical VT.
DISCUSSION
Unmappable VTs are still considered a limitation of RFA,
and no definitive approach has been widely accepted.
Marchlinski et al. (16) recently described a method in which
identification of the scar and exit site by means of pace
mapping was used to decide where to create lines of ablation
to treat unmappable VT in patients with chronic myocardial
infarction and arrhythmogenic right ventricular dysplasia.
Table 3. Ablation Guidance and Recurrences During Follow-Up
Patient
No.
Ablation Site
Guidance
Follow-Up
(months)
Recurrences
(no. of episodes)
1 E-IDC 17 0
2 E-IDC 4 0
3 E-IDC 16 0
4 E-IDC 9 1
5 E-IDC 12 0
6 E-IDC 12 0
7 E-IDC 12 VF
8 E-IDC 11 0
9 E-IDC 10 0
10 E-IDC 12 0
11 E-IDC 12 0
12 E-IDC 12 0
13 E-IDC 10 0
14 E-IDC 19 1 (different VT)
15 E-IDC 7 0
16 E-IDC 7 0
17 E-IDC 2 2 (different VT)
18 E-IDC 7 multiple
19 C-EM 7 multiple
20 C-EM 12 0
21 C-EM 6 0
22 C-EM 10 0
23 C-EM 7 0
24 C-EM 5 0
C-EM  conventional entrainment-mapping; E-IDC  electrograms with isolated,
delayed component; VF  ventricular fibrilation; VT  ventricular tachycardia.
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We describe a new method of treatment of monomorphic
VT that can be feasibly applied to patients with unmappable
VT. This method is based on the recording of electrograms
that identify slow conduction areas during SR and RVA
pacing. This method overcomes the limitations detected in
previous studies, in which the recording of simply abnormal
low-voltage electrograms was highly nonspecific due to the
extensive areas in which they were located (9). The criterion
we selected for identification of the VT substrate was based
on the observation that late and long-duration electrograms,
despite a low sensitivity, were highly specific for VT circuit
identification (10); this criterion also required the recording
of high-frequency electrograms with multiple components
separated by an isoelectric line, similar to the electrograms
recorded at the central common pathways or adjacent
bystander (17). This type of electrogram, although unable to
differentiate the central isthmus from a closed bystander,
reduced the area of interest, increasing the specificity, as can
be appreciated when voltage maps are studied. It is impor-
tant to notice that RVA pacing permitted the identification
of the VT substrate in several patients in whom the SR map
was not sensitive enough, supporting our hypothesis that a
change in the direction of the activation front might unmask
some areas of block and slow conduction. These data are in
agreement with those reported previously by Brunckhorst et
al. (18), in which multipotential electrograms with 2
deflection, highly predictive of a reentrant circuit, were
more frequently recorded during right ventricular pacing.
Moreover, we can speculate that during SR, several simul-
taneous activation wave fronts may coexist, making the
probability of electrogram overlap higher than during RVA
pacing, when only one activation wave front is present.
Location of E-IDC. Voltage maps showed that E-IDC
areas were located inside the dense scar tissue. These results
are compatible with those obtained during surgical treat-
ment of VT in which the electrogram recorded at sites
related to VT had a voltage amplitude 0.5 mV (19), as
well as with those data more recently reported in which the
fractionated electrograms were always recorded in dense scar
(20).
Advantages of ablation of E-IDC areas. The E-IDC
areas are relatively small compared with scar areas; there-
fore, this method permits a focus on the diagnostic tech-
niques and ablation in defined areas. This procedure allows
the ablation of some nontolerated VTs not approachable by
conventional entrainment mapping, as: 1) the recording of
E-IDC before and during VT induction serves to relate
E-IDCs and VT within seconds, provided that the IDC
precedes the first VT beat and then becomes mid-diastolic;
and 2) the ablation of all IDC sites overcomes the lack of
specificity of the selection of a single site as an ablation
target when entrainment mapping criteria are not fulfilled.
Ablation of these electrograms could also eliminate the
substrate for different VTs otherwise not ablated by limited
conventional strategies.
Study limitations. In patients with inducible and nontol-
erated VT, we could not differentiate between the E-IDC
recorded in the central common pathway of the circuit from
those recorded in areas probably connected but not related
to the VT circuit, as an adjacent bystander. Nevertheless,
isolated potentials are usually recorded near the central
common pathway (17). In few patients with more than one
clinical VT, not all VTs could be related to the E-IDC
areas; a nonendocardial circuit and the complexity of some
circuits in which several exit sites coexist might preclude the
reproduction of certain morphologies. Moreover, this treat-
ment strategy has not proven its efficacy in patients with
nontolerated and undocumented VTs, mainly when these
patients have more than one E-IDC area. In patients with
a low frequency of episodes, it is not possible to determine
the long-term efficacy of the procedure. A reduction in
ventricular function was not systematically evaluated; nev-
ertheless, no clinical deterioration related to the procedure
was observed.
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